217 related articles for article (PubMed ID: 18832842)
21. Evolving issues in the management of reflux disease?
Yuan Y; Hunt RH
Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
[TBL] [Abstract][Full Text] [Related]
22. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
Gyawali CP
Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
[TBL] [Abstract][Full Text] [Related]
23. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
24. Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.
Bytzer P; Blum AL
Aliment Pharmacol Ther; 2004 Aug; 20(4):389-98. PubMed ID: 15298632
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
26. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease.
Gosselin A; Luo R; Lohoues H; Toy E; Lewis B; Crawley J; Duh MS
Value Health; 2009; 12(1):34-9. PubMed ID: 19895371
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
Hiyama T; Matsuo K; Urabe Y; Fukuhara T; Tanaka S; Yoshihara M; Haruma K; Chayama K
J Gastroenterol Hepatol; 2009 Aug; 24(8):1326-32. PubMed ID: 19702900
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients.
Coron E; Sebille V; Cadiot G; Zerbib F; Ducrotte P; Ducrot F; Pouderoux P; Arts J; Le Rhun M; Piche T; Bruley des Varannes S; Galmiche JP;
Aliment Pharmacol Ther; 2008 Nov; 28(9):1147-58. PubMed ID: 18616516
[TBL] [Abstract][Full Text] [Related]
29. On-demand therapy is a valid strategy in GERD patients: pros and cons.
Leodolter A; Penagini R
Dig Dis; 2007; 25(3):175-8. PubMed ID: 17827935
[TBL] [Abstract][Full Text] [Related]
30. Precise role of acid in non-erosive reflux disease.
Wang C; Hunt RH
Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
[TBL] [Abstract][Full Text] [Related]
31. [Dyspepsia and heartburn in primary care: a rational and economic approach].
Labenz J
MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
[No Abstract] [Full Text] [Related]
32. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
33. Medical management of gastroesophageal reflux disease.
Wang C; Hunt RH
Gastroenterol Clin North Am; 2008 Dec; 37(4):879-99, ix. PubMed ID: 19028323
[TBL] [Abstract][Full Text] [Related]
34. Dexlansoprazole MR: a review.
Hershcovici T; Jha LK; Fass R
Ann Med; 2011 Aug; 43(5):366-74. PubMed ID: 21366513
[TBL] [Abstract][Full Text] [Related]
35. Gastroesophageal reflux disease (GERD): is there more to the story?
Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
[TBL] [Abstract][Full Text] [Related]
36. New developments in gastroesophageal reflux disease diagnosis and therapy.
Ali T; Miner PB
Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167
[TBL] [Abstract][Full Text] [Related]
37. Esophagitis in children: an update on current pharmacotherapy.
Shashidhar H; Tolia V
Expert Opin Pharmacother; 2013 Dec; 14(18):2475-87. PubMed ID: 24138403
[TBL] [Abstract][Full Text] [Related]
38. Managed care issues in the treatment of gastroesophageal reflux disease.
DeVault KR
Am J Manag Care; 2000 Oct; 6(16 Suppl):S871-5. PubMed ID: 11184657
[TBL] [Abstract][Full Text] [Related]
39. Evidence-based assessment of the efficacy of esomeprazole for the healing of erosive esophagitis.
Johnson DA
Expert Rev Pharmacoecon Outcomes Res; 2004 Aug; 4(4):371-82. PubMed ID: 19807296
[TBL] [Abstract][Full Text] [Related]
40. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
Inotai A; Mészáros A
Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
